Laddar...

A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya)

Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system (CNS) through demyelination and neurodegeneration. Until recently, major therapeutic treatments have relied on agents requiring injection delivery. In September 2010, fingolimod/FTY720 (Gilenya, Novartis) w...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Chun, Jerold, Brinkmann, Volker
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2011
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3694567/
https://ncbi.nlm.nih.gov/pubmed/21955849
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!